Roche: The Undervalued Swiss Pharma Giant Otcmkts:rhhbf
Primarily based on an analysis of recent regulatory filings, personnel stand to reap much more than $2 billion altogether from these options, with the major excutives integrated. The Swiss drugmaker then improved that bid to $93 per share last Friday. Roche recently said it...